Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3RUX

Crystal structure of biotin-protein ligase BirA from Mycobacterium tuberculosis in complex with an acylsulfamide bisubstrate inhibitor

3RUX の概要
エントリーDOI10.2210/pdb3rux/pdb
関連するPDBエントリー2CGH 3L1A 3L2Z
分子名称BirA bifunctional protein, 5'-deoxy-5'-[({5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanoyl}sulfamoyl)amino]adenosine (3 entities in total)
機能のキーワードbiotin-protein ligase, ligase-ligase inhibitor complex, ligase/ligase inhibitor
由来する生物種Mycobacterium tuberculosis
タンパク質・核酸の鎖数2
化学式量合計58212.12
構造登録者
Geders, T.W.,Finzel, B.C. (登録日: 2011-05-05, 公開日: 2011-12-14, 最終更新日: 2024-02-28)
主引用文献Duckworth, B.P.,Geders, T.W.,Tiwari, D.,Boshoff, H.I.,Sibbald, P.A.,Barry, C.E.,Schnappinger, D.,Finzel, B.C.,Aldrich, C.C.
Bisubstrate Adenylation Inhibitors of Biotin Protein Ligase from Mycobacterium tuberculosis.
Chem.Biol., 18:1432-1441, 2011
Cited by
PubMed Abstract: The mycobacterial biotin protein ligase (MtBPL) globally regulates lipid metabolism in Mtb through the posttranslational biotinylation of acyl coenzyme A carboxylases involved in lipid biosynthesis that catalyze the first step in fatty acid biosynthesis and pyruvate coenzyme A carboxylase, a gluconeogenic enzyme vital for lipid catabolism. Here we describe the design, development, and evaluation of a rationally designed bisubstrate inhibitor of MtBPL. This inhibitor displays potent subnanomolar enzyme inhibition and antitubercular activity against multidrug resistant and extensively drug resistant Mtb strains. We show that the inhibitor decreases in vivo protein biotinylation of key enzymes involved in fatty acid biosynthesis and that the antibacterial activity is MtBPL dependent. Additionally, the gene encoding BPL was found to be essential in M. smegmatis. Finally, the X-ray cocrystal structure of inhibitor bound MtBPL was solved providing detailed insight for further structure-activity analysis. Collectively, these data suggest that MtBPL is a promising target for further antitubercular therapeutic development.
PubMed: 22118677
DOI: 10.1016/j.chembiol.2011.08.013
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.7 Å)
構造検証レポート
Validation report summary of 3rux
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon